Veracyte reported $3.92B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Agilent USD 32.66B 5.2B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Illumina USD 17.88B 2.74B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 160.86B 30.46B Mar/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.57B 758M Mar/2026
Waters USD 29.87B 7.25B Mar/2026